We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BioLegend Antibodies for Detection of α-Synuclein

Product News   Jun 06, 2017

 
BioLegend Antibodies for Detection of α-Synuclein
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Impel Neuropharma Presents Data for the 2020 Migraine Trust Virtual Symposium

Product News

Impel NeuroPharma announced that it has presented patient-reported outcomes data from the Company’s pivotal Phase 3, open-label study “STOP 301” of INP104 (dihydroergotamine mesylate) or DHE using the company’s proprietary POD technology, for the treatment of acute migraine in an oral presentation at the Migraine Trust Virtual Symposium (MTIS) to be held from October 3-9, 2020.

READ MORE

CZI Awards $4.5M to Advance Innovative Approaches to Fighting Neurodegenerative Diseases

Product News

The Chan Zuckerberg Initiative has announced $4.5 million in funding to support 30 pairs of researchers to collaborate and apply novel approaches for gaining greater insight into neurodegenerative disorders.

READ MORE

Cobra Biologics Delivers Final Plasmids for Production of CG01 in CombiGene's Epilepsy Project

Product News

The milestone in the project paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy.

READ MORE

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE